MIMS news

Further monthly injectable migraine prophylactic launched

Further monthly injectable migraine prophylactic launched

With the launch of Emgality (galcanezumab), prescribers...

Updated bowel disease treatment summaries published by MIMS

Updated bowel disease treatment summaries published by MIMS

Updated quick-reference summaries of the latest NICE...

Boys to be vaccinated against HPV from September

Boys to be vaccinated against HPV from September

The routine HPV vaccination programme is to be extended...

Compare vitamin D supplements with new MIMS table

Compare vitamin D supplements with new MIMS table

MIMS has published a new table summarising key information...

Bath emollients among further prescribing restrictions issued by NHS England

Bath emollients among further prescribing restrictions issued by NHS England

GPs should no longer routinely prescribe bath and shower...

New non-oestrogen treatment for vaginal menopause symptoms

New non-oestrogen treatment for vaginal menopause symptoms

Intrarosa (prasterone) is a new topical treatment for...

New migraine prophylactic for monthly or quarterly injection

New migraine prophylactic for monthly or quarterly injection

Fremanezumab (Ajovy) is a monoclonal antibody licensed...

No need to restrict dietary vitamin K intake in patients on warfarin, say researchers

No need to restrict dietary vitamin K intake in patients on warfarin, say researchers

Increasing dietary vitamin K intake may be beneficial...

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

Reduce insulin doses carefully when starting GLP-1 agonists, MHRA advises

A careful stepwise approach is needed when reducing...

Prescribers advised not to use newer anticoagulants in patients with antiphospholipid syndrome

Prescribers advised not to use newer anticoagulants in patients with antiphospholipid syndrome

Direct-acting oral anticoagulants (DOACs) should not...

Novel MS drug gains NICE approval

Novel MS drug gains NICE approval

New NICE guidance recommends ocrelizumab (Ocrevus)...

NICE recommends new triple therapy option for diabetes

NICE recommends new triple therapy option for diabetes

Ertugliflozin (Steglatro) can now be prescribed routinely...

Licensed melatonin treatment now available for children with autism

Licensed melatonin treatment now available for children with autism

GPs can now prescribe melatonin as a licensed prolonged-release...

Second DPP4 inhibitor/SGLT2 inhibitor tablet launched for patients with diabetes

Second DPP4 inhibitor/SGLT2 inhibitor tablet launched for patients with diabetes

Prescribers can now consider Glyxambi (linagliptin/empagliflozin)...

Treatment of subclinical hypothyroidism questioned in controversial new guidance

Treatment of subclinical hypothyroidism questioned in controversial new guidance

GPs should monitor patients with subclinical hypothyroidism...

New combination diabetes treatment launched

New combination diabetes treatment launched

Suliqua is a titratable, fixed-ratio combination of...

Last chance to register for the next Respiratory and Allergy Learning Series event

Last chance to register for the next Respiratory and Allergy Learning Series event

Join us in Leicester on 19th June for the next MIMS...

Opioid de-prescribing toolkit launched

Opioid de-prescribing toolkit launched

Researchers at the University of East Anglia (UEA)...

Check current drug shortages with a new tracker from MIMS

Check current drug shortages with a new tracker from MIMS

GPs can reduce their likelihood of writing prescriptions...

Two new steroid inhalers launched

Two new steroid inhalers launched

A new beclometasone metered-dose inhaler and a new...